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Clinical relevance of rapid identiﬁcation of
candidemia usinga dual color PNA FISH assay
S. Whittier ∗, P. Della-Latta
NYP/Columbia Uiversity Medical Center, New York,
USA
Background: Candida species are the fourth most common
bloodstream infection with the highest crude mortality rate. Rapid
identiﬁcationof thesepathogensdirectly fromnewlypositiveblood
cultures (BC) can impact patient management by providing early
appropriate empiric antifungal therapy. This study evaluated the
impact of rapid detection of the predominant causes of candidemia,
namely Candida albicans (CA) and Candida glabrata (CG), using the
C. albicans/C. glabrata PNA FISH assay (AdvanDx Inc.; Woburn, MA).
The effect of pathogen detection in real time on the selection of
or change to appropriate antifungal treatment was measured. Real
time differentiation of ﬂuconazole susceptible CA strains from ﬂu-
conazole non-susceptible CG is an important component of an
effective antibiotic stewardship programand can beused as a guide
to empiric therapy.
Methods & Materials: Fluorescent labeled Peptide Nucleic Acid
(PNA) probes targeting speciﬁc 26S rRNA sequences of CA and CG
are utilized in the ﬂuorescence in situ hydridization dual color C.
albicans/C. glabrata PNA FISH assay. CA and CG are identiﬁed as
brightgreenor redﬂuorescent cells, respectively. Identiﬁcationwas
compared to conventional culture methods. Patient records were
reviewed retrospectively for therapeutic changes based on rapid
reporting.
Results: FromJan throughNov 2013, 72 newly positive BCswith
Gram stains positive for yeast, collected from 42 patients, were
tested. The PNA FISH accurately identiﬁed 32 patients with BCs
containing CA and/or CG, representing 76% of fungal BSIs, within
90minutes compared to 24-48hours by culture. Of the remaining
10 patients, the majority were infected with Candida parapsilosis
(7). The sensitivity, speciﬁcity, positive and negative predictive val-
ues for the assay compared to culture were 100%. Rapid reporting
resulted in therapy modiﬁcations for 42% of patients positive for
CA and 71% of patients positive for CG.
Conclusion: C. albicans/C. glabrata PNA FISH is a highly sensitive
and speciﬁc assay for identifying CA and CG from BCs in real-time
(90minutes compared to 1-3 days with culture). The ability to
rapidly obtain species speciﬁc results is clinically useful in target-
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Arctic Circle Antibiotic Stewardship: An
intervention with rapidly reduced in-patient
antibiotic use
T.N. Gustafsson ∗, A. Nystedt
Sunderby Hospital, Lulea, Sweden
Background: The Norrbotten County is the largest and north-
ernmost county in Sweden and is situated around the Arctic Circle.
It comprises about 25% of the total land area but with only 250 000
inhabitants (2.5% of the population). The county has 4 small (45-
120 beds) and one medium sized (380 beds) hospital. There is one
infectious disease clinic in the county located at the largest hospi-
tal providing specialized infectious disease care and consultation
services for the whole county. The four smaller hospitals have tra-
ditionally been characterized by a higher relative consumption of
antibiotics. The hypothesis was that this might be due to the lack
of infectious disease (ID) physicians available on site.
Methods & Materials: In the fall of 2012 an intervention was
started where an ID-physician visits each of the four smaller
hospitals once a week, reviewing all admitted patients currently
receiving antibiotics. The indication for therapy is reviewed and
the choice of antibiotic is scrutinized with the intention to suspend
unnecessary treatments and help to ﬁnd more suitable, narrow
spectrum, antibiotics whenever possible. The larger hospital did
not receive an intervention (although long-standing consultations
in hematology, ICU etc. were kept) and served as the control group.
We analyzed the consumption of antibiotics using data from the
Concise database (Apotekens Service AB), which collects nation-
wide data on all antibiotics sold in Sweden. The primary endpoint
was total in-patient consumption of antibiotics for the intervention
group versus the control group, before and after the intervention.
Results: Three out of four hospitals in the intervention group
decreased their in-patient antibiotic consumption by 5-17%. The
total reduction for the whole intervention group was 9%. The con-
trol hospital on the other hand, increased its consumption by 4%
during the same time period. Furthermore, a shift from broad
spectrum antibiotics towards narrow spectrum alternatives was
observed.
Conclusion: A rapid, substantial reduction in in-patient con-
sumption of antibiotics can be achieved through an active,
ID-physician run, antibiotic stewardship program. This seems to
hold true even in areas where geographical aspects do not permit
for every-day, in-house, presence of an ID-physician.
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